Tissue Renin-Angiotensin-Aldosterone Systems: Targets for Pharmacological Therapy

被引:255
作者
Bader, Michael [1 ]
机构
[1] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany
关键词
reactive oxygen species; bradykinin; nitric oxide; hypertension; cardiac hypertrophy; signaling; LEFT-VENTRICULAR DYSFUNCTION; ELEVATED BLOOD-PRESSURE; CONVERTING ENZYME 2; II TYPE-1 RECEPTOR; FIBRILLARY ACIDIC PROTEIN; IN-SITU HYBRIDIZATION; SMOOTH-MUSCLE-CELLS; END-ORGAN DAMAGE; TRANSGENIC MICE; MYOCARDIAL-INFARCTION;
D O I
10.1146/annurev.pharmtox.010909.105610
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The renin-angiotensin-aldosterone system is one of the most important systems in cardiovascular control and in the pathogenesis of cardiovascular diseases. Therefore, it is already a very successful drug target for the therapy of these diseases. However, angiotensins are generated not only in the plasma but also locally in tissues from precursors and substrates either locally expressed or imported from the circulation. In most areas of the brain, only locally generated angiotensins can exert effects oil their receptors owing to the blood-brain barrier. Other tissue renin-angiotensin-aldosterone systems are found in cardiovascular organs Such as kidney, heart, and vessels and play important roles in the function of these organs and in the deleterious actions of hypertension and diabetes on these tissues. Novel components with mostly opposite actions to the classical renin-angiotensin-aldosterone systems have been described and need functional characterization to evaluate their suitability as novel drug targets.
引用
收藏
页码:439 / 465
页数:27
相关论文
共 209 条
[1]   AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration [J].
AbdAlla, S ;
Lother, H ;
Quitterer, U .
NATURE, 2000, 407 (6800) :94-98
[2]  
Aguilera G, 1996, ADV EXP MED BIOL, V396, P105
[3]   Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction [J].
Ainscough, Justin F. X. ;
Drinkhill, Mark J. ;
Sedo, Alicia ;
Turner, Neil A. ;
Brooke, David A. ;
Balmforth, Anthony J. ;
Ball, Stephen G. .
CARDIOVASCULAR RESEARCH, 2009, 81 (03) :592-600
[4]  
ALENINA N, 2008, EXP PHYSIOL, V93, P5328
[5]   Localization and function of angiotensin AT1 receptors [J].
Allen, AM ;
Zhuo, JL ;
Mendelsohn, FAO .
AMERICAN JOURNAL OF HYPERTENSION, 2000, 13 (01) :31S-38S
[6]  
[Anonymous], 2004, DIABETES CARE, V27, pS79, DOI DOI 10.2337/DIACARE.27.5.1240-A
[7]   ENDOTHELIN-1 AND ITS BINDING-SITES ARE UP-REGULATED IN PRESSURE-OVERLOAD CARDIAC-HYPERTROPHY [J].
ARAI, M ;
YOGUCHI, A ;
ISO, T ;
TAKAHASHI, T ;
IMAI, S ;
MURATA, K ;
SUZUKI, T .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 268 (05) :H2084-H2091
[8]   An update on non-peptide angiotensin receptor antagonists and related RAAS modulators [J].
Aulakh, G. K. ;
Sodhi, R. K. ;
Singh, M. .
LIFE SCIENCES, 2007, 81 (08) :615-639
[9]   Angiotensin peptides and baroreflex control of sympathetic outflow: Pathways and mechanisms of the medulla oblongata [J].
Averill, DB ;
Diz, DI .
BRAIN RESEARCH BULLETIN, 2000, 51 (02) :119-128
[10]   Molecular interactions of vasoactive systems in cardiovascular damage [J].
Bader, M .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 38 :S7-S9